| Cat.No. : |
IL1RN-945E
Optional Service: Optional requirements on this protein
|
| Product Overview : |
Recombinant Equine IL1RN (Accession # O18999.1) His26-Gln177, fused with an N-terminal Met, was produced in E. coli. |
| Source : |
E. coli |
| Species : |
Equine |
| Predicted N Terminal : |
Met |
| Form : |
Lyophilized from a 0.2 µm filtered solution in PBS and DTT with BSA as a carrier protein. |
| Bio-activity : |
Measured by its ability to inhibit IL-1 alpha -dependent proliferation in D10.G4.1 mouse helper T cells. Symons, J.A. et al. (1987) in Lymphokines and Interferons, a Practical Approach. Clemens, M.J. et al. (eds): IRL Press. 272.The ED50 for this effect is typically 0.75 - 3.0 µg/mL in the presence of 50 pg/mL of rhIL-1 alpha. |
| Molecular Mass : |
Recombinant Equine IL1RN, Met-tagged has a calculated MW of 17.5 kDa. |
| Protein length : |
His26-Gln177 |
| Purity : |
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| Storage : |
Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC). |
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
